Copyright
©The Author(s) 2021.
World J Clin Cases. Dec 26, 2021; 9(36): 11183-11192
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11183
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11183
Total cohort | Negative biopsy | Positive biopsy | P value | |
Patients, n | 127 | 60 | 67 | - |
Age (yr), median (IQR) | 68 (63-74) | 66 (61-70) | 70 (65-78) | < 0.001 |
BMI (kg/m2), median (IQR) | 24.8 (22.64-26.54) | 24.48 (23.03-26.56) | 24.77 (22.49-26.26) | 0.466 |
PSA (ng/ml), median (IQR) | 8.51 (5.43-11.40) | 7.04 (5.06-11.01) | 8.96 (5.81-12.01) | 0.056 |
Prostate volume (cm3), median (IQR) | 36.30 (26.80-46.20) | 42.67 (31.58-58.23) | 32.10 (23.20-39.65) | < 0.001 |
PSAD (ng/ml/cm3), median (IQR) | 0.23 (0.14-0.34) | 0.16 (0.12-0.25) | 0.30 (0.18-0.43) | < 0.001 |
Largest dimention (cm), median (IQR) | 1.10 (0.70-1.30) | 1.05 (0.53-1.28) | 1.10 (0.80-1.40) | |
PI-RADS | 4 (3-5) | 3 (3-5) | 4(3-5) | < 0.001 |
3 (n/%) | 57 (44.9) | 46 (76.7) | 11 (16.4) | |
4 (n/%) | 41 (32.3) | 12 (20.0) | 29 (43.3) | |
5 (n/%) | 29 (22.8) | 2 (3.3) | 27 (40.3) | |
Location, n (%) | 0.054 | |||
TZ | 41 (32.3) | 23 (38.3) | 18 (26.9) | |
PZ | 75 (59.1) | 35 (58.3) | 49 (59.7) | |
Both | 0.054 | 2 (3.3) | 9 (13.4) | |
Total cores, n, median (IQR) | 19 (17-22) | 20 (18-22) | 18 (15-22) | 0.046 |
Targeted | 5 (4-8) | 5 (3-8) | 6 (4-8) | |
Randomized | 14 (11-16) | 14 (12-16) | 13 (10-16) |
- Citation: Pang C, Wang M, Hou HM, Liu JY, Zhang ZP, Wang X, Zhang YQ, Li CM, Zhang W, Wang JY, Liu M. Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer. World J Clin Cases 2021; 9(36): 11183-11192
- URL: https://www.wjgnet.com/2307-8960/full/v9/i36/11183.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i36.11183